115 related articles for article (PubMed ID: 32511873)
1. Ethnicity and insurance status predict metastatic disease presentation in prostate, breast, and non-small cell lung cancer.
Aghdam N; McGunigal M; Wang H; Repka MC; Mete M; Fernandez S; Dash C; Al-Refaie WB; Unger KR
Cancer Med; 2020 Aug; 9(15):5362-5380. PubMed ID: 32511873
[TBL] [Abstract][Full Text] [Related]
2. The effect of socioeconomic status, race, and insurance type on newly diagnosed metastatic prostate cancer in the United States (2004-2013).
Weiner AB; Matulewicz RS; Tosoian JJ; Feinglass JM; Schaeffer EM
Urol Oncol; 2018 Mar; 36(3):91.e1-91.e6. PubMed ID: 29153624
[TBL] [Abstract][Full Text] [Related]
3. Association of insurance status and ethnicity with cancer stage at diagnosis for 12 cancer sites: a retrospective analysis.
Halpern MT; Ward EM; Pavluck AL; Schrag NM; Bian J; Chen AY
Lancet Oncol; 2008 Mar; 9(3):222-31. PubMed ID: 18282806
[TBL] [Abstract][Full Text] [Related]
4. Non-Small Cell Lung Cancer as a Second Primary Among Patients With Previous Malignancy: Who Is at Risk?
Wu GX; Nelson RA; Kim JY; Raz DJ
Clin Lung Cancer; 2017 Sep; 18(5):543-550.e3. PubMed ID: 28412093
[TBL] [Abstract][Full Text] [Related]
5. Associations of Socioeconomic Status, Public vs Private Insurance, and Race/Ethnicity With Metastatic Sarcoma at Diagnosis.
Diessner BJ; Weigel BJ; Murugan P; Zhang L; Poynter JN; Spector LG
JAMA Netw Open; 2020 Aug; 3(8):e2011087. PubMed ID: 32766799
[TBL] [Abstract][Full Text] [Related]
6. Differences in Breast Cancer Stage at Diagnosis by Ethnicity, Insurance Status, and Family Income in Young Women in the USA.
Franzoi MA; Schwartsmann G; de Azevedo SJ; Geib G; Zaffaroni F; Liedke PER
J Racial Ethn Health Disparities; 2019 Oct; 6(5):909-916. PubMed ID: 31102102
[TBL] [Abstract][Full Text] [Related]
7. Disparities in disease presentation in the four screenable cancers according to health insurance status.
Amini A; Jones BL; Yeh N; Guntupalli SR; Kavanagh BD; Karam SD; Fisher CM
Public Health; 2016 Sep; 138():50-6. PubMed ID: 27091437
[TBL] [Abstract][Full Text] [Related]
8. Association of insurance and race/ethnicity with disease severity among men diagnosed with prostate cancer, National Cancer Database 2004-2006.
Fedewa SA; Etzioni R; Flanders WD; Jemal A; Ward EM
Cancer Epidemiol Biomarkers Prev; 2010 Oct; 19(10):2437-44. PubMed ID: 20705937
[TBL] [Abstract][Full Text] [Related]
9. The association between insurance status and prostate cancer outcomes: implications for the Affordable Care Act.
Mahal BA; Aizer AA; Ziehr DR; Hyatt AS; Lago-Hernandez C; Chen YW; Choueiri TK; Hu JC; Sweeney CJ; Beard CJ; D'Amico AV; Martin NE; Trinh QD; Nguyen PL
Prostate Cancer Prostatic Dis; 2014 Sep; 17(3):273-9. PubMed ID: 24980272
[TBL] [Abstract][Full Text] [Related]
10. The Impact of Insurance Status on Tumor Characteristics and Treatment Selection in Contemporary Patients With Prostate Cancer.
Fossati N; Nguyen DP; Trinh QD; Sammon J; Sood A; Larcher A; Guazzoni G; Montorsi F; Briganti A; Menon M; Abdollah F
J Natl Compr Canc Netw; 2015 Nov; 13(11):1351-8. PubMed ID: 26553765
[TBL] [Abstract][Full Text] [Related]
11. Factors contributing to disparities in mortality among patients with non-small-cell lung cancer.
Mehta AJ; Stock S; Gray SW; Nerenz DR; Ayanian JZ; Keating NL
Cancer Med; 2018 Nov; 7(11):5832-5842. PubMed ID: 30264921
[TBL] [Abstract][Full Text] [Related]
12. Association of Insurance Status and Racial Disparities With the Detection of Early-Stage Breast Cancer.
Ko NY; Hong S; Winn RA; Calip GS
JAMA Oncol; 2020 Mar; 6(3):385-392. PubMed ID: 31917398
[TBL] [Abstract][Full Text] [Related]
13. Impact of Socioeconomic Status on Pretreatment Weight Loss and Survival in Non-Small-Cell Lung Cancer.
Lau SKM; Gannavarapu BS; Carter K; Gao A; Ahn C; Meyer JJ; Sher DJ; Jatoi A; Infante R; Iyengar P
J Oncol Pract; 2018 Apr; 14(4):e211-e220. PubMed ID: 29558251
[TBL] [Abstract][Full Text] [Related]
14. Patient and tumour characteristics associated with inclusion in Cancer patient pathways in Norway in 2015-2016.
Nilssen Y; Brustugun OT; Eriksen MT; Haug ES; Naume B; Møller B
BMC Cancer; 2020 May; 20(1):488. PubMed ID: 32473650
[TBL] [Abstract][Full Text] [Related]
15. Comparing the Association Between Insurance and Mortality in Ovarian, Pancreatic, Lung, Colorectal, Prostate, and Breast Cancers.
Cole AP; Lu C; Krimphove MJ; Szymaniak J; Sun M; Fletcher SA; Lipsitz SR; Mahal BA; Nguyen PL; Choueiri TK; Kibel AS; Haider AH; Trinh QD
J Natl Compr Canc Netw; 2019 Sep; 17(9):1049-1058. PubMed ID: 31487683
[TBL] [Abstract][Full Text] [Related]
16. Real-world treatment patterns and costs in a US Medicare population with metastatic squamous non-small cell lung cancer.
Davis KL; Goyal RK; Able SL; Brown J; Li L; Kaye JA
Lung Cancer; 2015 Feb; 87(2):176-85. PubMed ID: 25532680
[TBL] [Abstract][Full Text] [Related]
17. 30-day mortality after systemic anticancer treatment for breast and lung cancer in England: a population-based, observational study.
Wallington M; Saxon EB; Bomb M; Smittenaar R; Wickenden M; McPhail S; Rashbass J; Chao D; Dewar J; Talbot D; Peake M; Perren T; Wilson C; Dodwell D
Lancet Oncol; 2016 Sep; 17(9):1203-16. PubMed ID: 27599138
[TBL] [Abstract][Full Text] [Related]
18. Impact of Insurance Status on Radiation Treatment Modality Selection Among Potential Candidates for Prostate, Breast, or Gynecologic Brachytherapy.
Grant SR; Walker GV; Koshy M; Shaitelman SF; Klopp AH; Frank SJ; Pugh TJ; Allen PK; Mahmood U
Int J Radiat Oncol Biol Phys; 2015 Dec; 93(5):968-75. PubMed ID: 26452570
[TBL] [Abstract][Full Text] [Related]
19. Does access to private healthcare influence potential lung cancer cure rates?
John TJ; Plekker D; Irusen EM; Koegelenberg CFN
S Afr Med J; 2017 Jul; 107(8):687-690. PubMed ID: 28809615
[TBL] [Abstract][Full Text] [Related]
20. Impact of insurance status on receipt of definitive surgical therapy and posttreatment outcomes in early stage lung cancer.
Stokes SM; Wakeam E; Swords DS; Stringham JR; Varghese TK
Surgery; 2018 Dec; 164(6):1287-1293. PubMed ID: 30170821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
